Killian Meara

Group is first to demonstrate the activation of inflammasome in response to infection by SARS-CoV-2.

COVID-19 is a dynamic disease which evolves as it disrupts host programs and rewires modules.

The research has helped almost 100 patients so far at the Royal Albert Edward Infirmary.

Can chemical compounds found in certain foods aid in the fight against COVID-19?

LabCorp, an early adopter with extensive geographic reach, will be the first lab offering the test in the United States.

Recent study may have implications for social and public health policies

Olfactory dysfunction is a critical loss of information that is important for responding to our environment.

Researchers produce the first-ever electron microscopy images of intact coronavirus particles within olfactory mucosa.

New study may help contribute to COVID-19 research.

Patients with pervasive conditions are found to be more at risk for a severe case of COVID-19.

Researchers find most common mutations appear to have been induced by the human immune system.

Important finding shows convalescent plasma provides no significant benefit in severe COVID-19 cases.

Recent study shows COVID-19 survivors health improves with support of Home Health Care.

An artificial intelligence (AI) algorithm predicts outcomes in patients diagnosed with COVID-19.

New study provides deep insights into the COVID-19 pandemic.

A recently created therapy for the influenza virus may help aid in the fight against COVID-19.

The guidelines were recently updated to reflect new information on COVID-19 treatment and management.

New details of SARS-CoV-2 have been obtained using 3D modeling, providing crucial insights into the disease.

National Institute of Allergy and Infectious Disease (NIAID) has selected Metabolon to participate in a study on this subject.

Study finds that a century-old tuberculosis vaccine could be used in the treatment and prevention of COVID-19.

Immunologists have discovered possible treatments for COVID-19 using existing therapies.

The measles-mumps-rubella (MMR) vaccine could potentially aid in the protection against COVID-19.

Two recent studies conducted by Kansas State University researchers resulted in important findings related to the current COVID-19 pandemic.

Meta-analysis shows people infected with SARS-CoV-2 are more highly infectious within the first week of showing symptoms.

Researchers have identified the Ski complex as a promising target for antiviral drugs in the fight against coronaviruses.

Gilead has announced that its investigational long-acting HIV-1 capsid inhibitor, lenacapavir, has achieved its primary endpoint in a phase 2/3 CAPELLA trial.

The US Food and Drug Administration has granted breakthrough therapy designation for an investigational drug, a long-acting, injectable cabotegravir for HIV pre-exposure-prophylaxis (PrEP).

SARS-CoV-2 outbreaks on 16 different mink farms in the Netherlands have been identified showing transmission between humans and minks.

New study finds casual links between obese people and the potential for a higher risk of COVID-19 infection